Welcome to our dedicated page for Mobix Labs SEC filings (Ticker: MOBX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Mobix Labs, Inc. (MOBX) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a fabless semiconductor and connectivity issuer listed on The Nasdaq Capital Market. Through these documents, investors can review how Mobix Labs reports on its RF, connectivity, interconnect and EMI filtering business, its capital structure and its financing activities.
Current and periodic reports such as Form 8‑K detail material events, including at‑the‑market offering agreements, warrant exercise inducement transactions, debt and equity financings, Nasdaq minimum bid‑price notices and extensions, and amendments to outstanding warrants that affect classification of these instruments as equity or liabilities. Certain 8‑K and 8‑K/A filings also describe leadership changes and advisory roles, as well as legal proceedings related to alleged failures to fund agreed‑upon investments.
Registration statements on Form S‑1 and Form S‑3, along with their amendments, outline registered offerings of Mobix Labs’ Class A common stock and the use of proceeds the company identifies, such as working capital, general corporate purposes, growth initiatives and M&A strategy. These filings also provide background on the company’s fabless semiconductor model, RF and connectivity focus, and risk factors.
Annual and quarterly reports on Forms 10‑K and 10‑Q, when filed, give a broader view of Mobix Labs’ financial condition, including revenue, gross margin, operating loss and liquidity metrics, as well as segment and market discussions. Preliminary, unaudited financial information referenced in news releases is later finalized in these periodic reports.
On Stock Titan, Mobix Labs filings are updated in near real time from EDGAR. AI‑powered summaries help explain complex sections of 10‑K and 10‑Q reports, highlight key points from 8‑K disclosures, and make it easier to interpret warrant, debt and equity terms. Users can also review ownership and insider‑related information when available through Forms 3, 4 and 5 to understand equity incentives and changes in beneficial holdings.
Mobix Labs, Inc. files a Prospectus Supplement amending its Form S-1 to register up to 24,127,116 shares of Class A Common Stock.
The supplement incorporates a Form 8-K disclosing results from the March 23, 2026 Annual Meeting: holders representing 43,982,421 Class A shares and 2,004,901 Class B shares (approximately 52.86% voting power as of February 27, 2026) were present or represented. Stockholders approved director elections, ratification of the independent auditor, a reverse stock split proposal, and a warrant proposal. The Company’s Class A shares trade on Nasdaq under MOBX, with a closing price of $0.4588 on March 24, 2026.
Mobix Labs, Inc. reported the results of its Annual Meeting of Stockholders held on March 23, 2026. Holders of 43,982,421 shares of Class A Common Stock and 2,004,901 shares of Class B Common Stock were represented, accounting for approximately 52.86% of the total voting power as of the February 27, 2026 record date, which constituted a quorum.
Stockholders elected Class A director nominees David Aldrich and Frederick Goerner, and Class B director nominee Keyvan Samini, with substantial majorities. They also ratified the selection of the independent registered public accounting firm, approved a Reverse Stock Split Proposal, and approved a Warrant Proposal, each with strong levels of support and no broker non-votes recorded.
Mobix Labs, Inc. registers the resale of up to 24,127,116 shares of Class A Common Stock by selling stockholders. The resale prospectus covers Offered Securities held by third parties (including 1,268,252 Warrant Shares and 3,856,854 RaGE consideration shares) and states the company will not receive proceeds from resale by the Selling Stockholders.
The prospectus discloses 101,072,226 shares of Class A Common Stock outstanding as of January 31, 2026. It also states that, if certain warrants are exercised for cash, the company would receive aggregate gross proceeds of approximately $15.6 million. The filing warns that the Offered Securities would represent approximately 23.9% of outstanding Class A shares as of January 31, 2026 and that such sales could materially depress the market price.
Mobix Labs, Inc. is asking stockholders to approve four key items at its 2026 virtual annual meeting. Investors will vote on electing Class II directors, ratifying PricewaterhouseCoopers LLP as auditor for the year ending September 30, 2026, and a reverse stock split.
The reverse split would reclassify and combine outstanding Class A and Class B shares at a ratio between 1:10 and 1:50, at the Board’s discretion, primarily to help regain compliance with Nasdaq’s $1.00 minimum bid price after a prior deficiency notice and extension through April 27, 2026.
Stockholders are also asked to approve, under Nasdaq Listing Rule 5635(d), potential issuance of up to 8,229,701 Class A shares on exercise of an Inducement Warrant, 384,053 shares on Placement Agent Warrants, and 1,000,000 shares on an additional warrant related to amended outstanding warrants.
Mobix Labs, Inc. announced that its board of directors approved an amendment and restatement of the company’s bylaws effective February 27, 2026. The key change lowers the quorum requirement for stockholder meetings from a majority of voting power to one-third of the voting power of outstanding shares entitled to vote, unless otherwise required by law, the certificate of incorporation or applicable stock exchange rules.
The full text of the amended and restated bylaws, including the revised quorum language in Section 1.5, is provided as Exhibit 3.1 to this report.
Mobix Labs, Inc. is soliciting votes at its 2026 Annual Meeting to elect directors, ratify PricewaterhouseCoopers LLP, approve a reverse stock split at a ratio between 1-for-10 and 1-for-50, and approve in accordance with Nasdaq Rule 5635(d) the issuance of up to 8,229,701, 384,053, and 1,000,000 shares of Class A Common Stock upon exercise of specified warrants.
Illustrative share counts as of January 31, 2026 show 101,072,226 shares of Class A Common Stock outstanding and 2,004,901 shares of Class B Common Stock outstanding; the reverse split would proportionally reduce outstanding shares within the approved ratio range.
Mobix Labs, Inc. is registering the resale of up to 24,127,116 shares of its Class A Common Stock for existing selling stockholders. The company itself is not selling shares and will receive no proceeds from these resales.
The registered shares include stock issued in financings and acquisitions, such as 16,161,787 warrant shares and 3,856,854 shares issued for the RaGE Systems acquisition. As of January 31, 2026, Mobix had 101,072,226 Class A and 2,004,901 Class B shares outstanding.
Mobix may receive up to approximately $15.6 million in gross cash proceeds only if certain outstanding warrants covered by this registration are exercised for cash. The filing emphasizes that the registered block is large, representing about 23.9% of Class A shares, and that resales, or expectations of resales, could significantly pressure the stock price.
MOBIX LABS ownership disclosure: Armistice Capital, LLC and Steven Boyd report beneficial ownership of 3,377,508 shares of Common Stock, representing 4.99% of the class as of 12/31/2025. The filing states Armistice Capital exercises voting and investment power over the shares held by Armistice Capital Master Fund Ltd.
The reporting persons file jointly under Rule 13d-1(k) and note the Master Fund has the right to receive dividends or sale proceeds. Signatures are dated 02/17/2026.
Mobix Labs, Inc. reported a net loss of $10.1 million for the three months ended December 31, 2025, narrower than the $19.8 million loss a year earlier. Revenue fell to $1.9 million from $3.2 million, with both product and services sales declining.
Gross profit dropped to $0.6 million, and interest expense increased to $1.4 million as total debt reached $6.3 million. Despite lower operating expenses, especially stock-based compensation, the company ended the quarter with only $0.3 million in cash, prompting a going concern warning about its ability to meet obligations over the next year.
Stockholders’ equity improved to $4.7 million from a deficit at September 30, 2025, helped by share issuances and warrant reclassification. After quarter-end, Mobix raised approximately $5.1 million net through a public offering of 30 million Class A shares at $0.20 each and issued additional make-whole shares to a lender.